Mouse Anti-HSD17B2 Recombinant Antibody (CBFYH-2007) (CBMAB-H3018-FY)

Lu, Y., Zhang, M., Zhang, J., Jiang, M., & Bai, G. (2023). Psoralen prevents the inactivation of estradiol and treats osteoporosis via covalently targeting HSD17B2. Journal of Ethnopharmacology, 311, 116426.

Zhang, Y., Fan, A., Li, Y., Liu, Z., Yu, L., Guo, J., ... & Chen, W. (2023). Single-cell RNA sequencing reveals that HSD17B2 in cancer-associated fibroblasts promotes the development and progression of castration-resistant prostate cancer. Cancer Letters, 566, 216244.

Kanemoto, Y., Nishimura, K., Hayakawa, A., Sawada, T., Amano, R., Mori, J., ... & Kato, S. (2022). A long non-coding RNA as a direct vitamin D target transcribed from the antisense strand of the human HSD17B2 locus. Bioscience Reports, 42(5), BSR20220321.

Bamodu, O. A., Tzou, K. Y., Lin, C. D., Hu, S. W., Wang, Y. H., Wu, W. L., ... & Wu, C. C. (2021). Differential but concerted expression of HSD17B2, HSD17B3, SHBG and SRD5A1 testosterone tetrad modulate therapy response and susceptibility to disease relapse in patients with prostate cancer. Cancers, 13(14), 3478.

Gao, X., Dai, C., Huang, S., Tang, J., Chen, G., Li, J., ... & Li, Z. (2019). Functional silencing of HSD17B2 in prostate cancer promotes disease progression. Clinical Cancer Research, 25(4), 1291-1301.

Osiński, M., Wirstlein, P., Wender-Ożegowska, E., Mikołajczyk, M., Jagodziński, P. P., & Szczepańska, M. (2018). HSD3B2, HSD17B1, HSD17B2, ESR1, ESR2 and AR expression in infertile women with endometriosis. Ginekologia polska, 89(3), 125-134.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Isotype control